secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001437749-23-024891
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Monopar receives Nasdaq notice for bid price deficiency; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Monopar on Aug 28, 2023 that bid price closed below $1.00 for 30 consecutive days.
- Company has 180 calendar days (until Feb 26, 2024) to regain compliance with minimum $1.00 bid price.
- To regain compliance, stock must close at $1.00 or more for at least 10 consecutive business days.
- If non-compliant by deadline, Monopar may qualify for a second 180-day cure period subject to other listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774923024891/0001437749-23-024891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774923024891/mnpr20230828_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-024891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer